Reaction profile

The FDA adverse-event record for pulmonary metastases

31 FDA reports name pulmonary metastases, a lower-volume reaction in the CVM extract (VeDDRA 2369). Plate stamps and neighbourhood peers follow.

#1983 of 2,481
by report volume (all reactions)
31
reports citing this reaction
77.4%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pulmonary metastases has 31 reports now versus 31 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pulmonary metastases changes

FDA AER · VeDDRA plate

Code 2369 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 31 reports
  • DEATH-HOT 77.4%
  • LOWER-Q #1983/2481
  • PHOTO-FINISH ABNORMAL TEST RESULT,…
  • SPECIES-DOG Dog · 23
  • DRUG-LEAD Bedinvetmab · 10
  • DESK-WIDE 17 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: ABNORMAL TEST RESULT, THYROID NOS (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Pulmonary metastases

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348ABNORMAL TEST RESULT,… · near31ALBUMIN HIGH, URINE · near31BILE ACIDS ABNORMAL,… · near31Clonic seizure · near31Pulmonary metastases · this …31Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Pulmonary metastases

Pulmonary metastases: high death-coded share in the FDA AER plate

Signature read: Pulmonary metastases's 77.4% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 31 named reports in the openFDA extract. Death-coded share is upper-third: 24 of 31 reports (77.4% of named reports). Nearest volume peer: ABNORMAL TEST RESULT, THYROID NOS (±0 reports). Lead species Dog (23). Lead co-reported drug Bedinvetmab (10).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 23
Cat 8

Breeds Most Affected

Crossbred Canine/dog 6
Domestic Shorthair 4
Shepherd Dog - German 2
Retriever - Labrador 2
Spaniel - Springer English 2
Spaniel - King Charles Cavalier 2
Domestic Mediumhair 2
Maltese 2
Collie (unspecified) 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Associated Drugs

Bedinvetmab 10
Gabapentin 8
Maropitant Citrate 6
Cefovecin 5
Grapiprant 4
Pimobendan 4
Liver Supplement 4
Oclacitinib Maleate 3
Toceranib Phosphate 3
Melarsomine Dihydrochloride 3
Hydromorphone 3
Ropivacaine 3
Trilostane 3
Cosyntropin 3
Spironolactone 3
Furosemide 3
Joint Supplement 2
Frunevetmab 2
Codeine 2
Galliprant 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pulmonary metastases (#1983 of 2,481 by report volume); death-coded 77.4%. PlainBreed reaction plate · death-coded share stamp 77.4% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →